---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-078588"
form_type: "8-K"
ticker: "MMED"
cik: "0002062583"
company_name: "MiniMed Group, Inc."
filed_at: "2026-06-29T13:22:39+00:00"
generated_at: "2026-06-29T13:24:14.613278+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# MiniMed expands board to 11; appoints David Endicott (Alcon CEO) and Linnea Burman (Medtronic SVP)

## Summary
- Board increased from 9 to 11; appointments effective June 29, 2026.
- David Endicott (Alcon CEO) appointed as class I director, independent, will serve on Compensation and Talent Committee.
- Linnea Burman (Medtronic SVP, Neurovascular) appointed as class II director; no compensation while Medtronic is affiliate.
- 2026 annual meeting set for Oct 9, 2026; record date Aug 11, 2026; stockholder proposals due July 26, nominations due July 17.

## SEC filing metadata
- accession: 0001104659-26-078588
- form_type: 8-K
- ticker: MMED
- cik: 0002062583
- company_name: MiniMed Group, Inc.
- filed_at: 2026-06-29T13:22:39+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.08, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2062583/000110465926078588/0001104659-26-078588-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2062583/000110465926078588/tm2619270d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-078588
- JSON: https://secwatch.observer/filing/0001104659-26-078588.json
- Plain text: https://secwatch.observer/filing/0001104659-26-078588.txt

## Key facts
- Executive change
  Linnea Burman was appointed as Class II Director at MiniMed Group, Inc..
  - Action: appointed
  - Role: Class II Director
  source text: On June 25, 2026, the Board of Directors (the “Board”) of MiniMed Group, Inc. (“MiniMed”) increased the size of the Board from nine to 11 and appointed David Endicott and Linnea Burman to serve as a directors of the Board to fill the resulting vacancies, effective June 29, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2062583/000110465926078588/0001104659-26-078588-index.htm
- Executive change
  David Endicott was appointed as Class I Director at MiniMed Group, Inc..
  - Action: appointed
  - Role: Class I Director
  source text: On June 25, 2026, the Board of Directors (the “Board”) of MiniMed Group, Inc. (“MiniMed”) increased the size of the Board from nine to 11 and appointed David Endicott and Linnea Burman to serve as a directors of the Board to fill the resulting vacancies, effective June 29, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2062583/000110465926078588/0001104659-26-078588-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.